| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Fred Telling is Director at OGEN. From March 2015 to December 2025, the filings on record show 9 open-market purchases and 3 sales. Fred Telling's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13K at current prices.
Historically, Fred Telling's trades have earned a middling insider score of 50/100 across 11 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -48.1%.
Net of sales, the OGEN filings show accumulation of 1,675,795 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2018 | OGEN Oragenics Inc | Director | Buy | 100,000 | $0.00 | - | +71.7% | |
| Jun 30, 2016 | OGEN Oragenics Inc | Director | Buy | 969,180 | $0.52 | $499,999.96 | +280.0% |